Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Aprepitant (MK0869) for Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients

View source ↗

Summary

This completed clinical trial evaluated the safety and efficacy of aprepitant for chemotherapy-induced nausea and vomiting in pediatric patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• EMEND (aprepitant)

Snippet

Sponsor: West Virginia University Healthcare | Conditions: Chemotherapy-Induced Nausea and Vomiting | Status: COMPLETED